Status:
COMPLETED
Individualized Assessment and Treatment for Alcoholism II
Lead Sponsor:
UConn Health
Collaborating Sponsors:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions:
Alcoholism
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The object of this study is to develop a treatment for alcohol use disorders that is more effective than current CB treatments. Through a 2009 R-21 pilot project the investigators developed a cognitiv...
Detailed Description
An 2009 R-21 pilot project developed a cognitive-behavioral treatment for alcohol use disorders that employs cellphone-based experience sampling (ES) to collect detailed patient data in near real-time...
Eligibility Criteria
Inclusion
- Participants must be at least 18 years old,
- Meet DSM-V criteria for Alcohol Use Disorder moderate-severe
- Willing to accept random assignment to any of the three conditions
Exclusion
- Acute medical or psychiatric problems that require inpatient treatment (e.g., acute psychosis, or suicide/homicide risk)
- Reading ability below the fifth grade level
- Lack of reliable transportation to the treatment site, or excessive commuting distance.
Key Trial Info
Start Date :
August 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2022
Estimated Enrollment :
173 Patients enrolled
Trial Details
Trial ID
NCT03233802
Start Date
August 1 2016
End Date
November 1 2022
Last Update
November 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UConn Health
Farmington, Connecticut, United States, 06030